Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain.

Multiple GOP-led states are trying to make it harder for women to access mifepristone, a pill used in nearly two-thirds of ...

Researchers anticipated rapamycin would enhance the effects of working out, while also initiating health improvements of its ...

The Trump administration is proposing wastewater testing to try to ferret out data on illegal drug use in real time, ...

By Padmanabhan Ananthan May 1 (Reuters) - The U.S. Food and Drug Administration on Friday approved Pfizer and Arvinas' breast ...

A new synthetic opioid, cychlorphine, is emerging in illicit drug markets and forensic labs, raising fresh concerns for ...

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

By Kamal Choudhury and Mariam Sunny April 30 (Reuters) - The U.S. Food and Drug Administration has approved Axsome ...

The FDA said the action recognizes the dire need for a drug to improve survival for pancreatic cancer patients, who face the ...

The case, Hikma v. Amarin, centers on ‘skinny labeling,’ a pathway that allows generic drugs to come to market faster.

Regeneron will be the final of 17 large pharmaceutical companies to sign such a drug pricing agreement with the Trump ...